Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Express Scripts
Colorcon
Accenture
US Department of Justice
Julphar
Farmers Insurance
Daiichi Sankyo
Moodys

Generated: February 16, 2019

DrugPatentWatch Database Preview

Nuvo Pharm Company Profile

« Back to Dashboard

What is the competitive landscape for NUVO PHARM, and when can generic versions of NUVO PHARM drugs launch?

NUVO PHARM has fourteen approved drugs.

There are four US patents protecting NUVO PHARM drugs.

Summary for Nuvo Pharm
US Patents:4
Tradenames:10
Ingredients:10
NDAs:14

Drugs and US Patents for Nuvo Pharm

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Nuvo Pharm OXYCODONE HYDROCHLORIDE oxycodone hydrochloride TABLET;ORAL 207119-001 Apr 12, 2016 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Nuvo Pharm DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate TABLET;ORAL 209799-003 Dec 28, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Nuvo Pharm PHENTERMINE HYDROCHLORIDE phentermine hydrochloride CAPSULE;ORAL 205019-002 Dec 5, 2014 AA RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Nuvo Pharm DEXTROAMPHETAMINE SULFATE dextroamphetamine sulfate TABLET;ORAL 210059-001 Oct 18, 2017 AA RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Nuvo Pharm HYDROXYZINE HYDROCHLORIDE hydroxyzine hydrochloride TABLET;ORAL 207122-001 Mar 29, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Nuvo Pharm OXYCODONE HYDROCHLORIDE oxycodone hydrochloride TABLET;ORAL 207119-003 Apr 12, 2016 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Nuvo Pharms Inc PENNSAID diclofenac sodium SOLUTION;TOPICAL 020947-001 Nov 4, 2009 DISCN Yes No 8,217,078 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for NUVO PHARM drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Topical Solution 2.0% ➤ Subscribe 2014-06-03
➤ Subscribe Topical Solution 1.5% ➤ Subscribe 2012-07-11
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Deloitte
Harvard Business School
Dow
Cipla
Healthtrust
Queensland Health
Cerilliant
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.